KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-93 Cr | ₹-44 Cr | ₹-33 Cr | ₹-43 Cr | ₹-27 Cr |
What is the latest Net Current Assets ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-93 Cr |
| Mar2024 | ₹-44 Cr |
| Mar2023 | ₹-33 Cr |
| Mar2022 | ₹-43 Cr |
| Mar2021 | ₹-27 Cr |
How is Net Current Assets of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-93 Cr | Negative | |
| Mar2024 | ₹-44 Cr | Negative | |
| Mar2023 | ₹-33 Cr | Negative | |
| Mar2022 | ₹-43 Cr | Negative | |
| Mar2021 | ₹-27 Cr | - | |
Compare Net Current Assets of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹125.3 Cr | -2.1% | -0.6% | -40.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | -2.1% |
-0.6% |
-40.8% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses